Can we spot late side effects in neuroblastoma survivors? new study aims to find out
NCT ID NCT06480526
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether it's possible to screen for long-term health problems in people who survived high-risk neuroblastoma. Researchers will evaluate survivors who finished treatment at least 2 years ago, using tests for heart, nerve, and other health issues. The goal is to see if enough survivors will take part in these comprehensive check-ups.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH-RISK NEUROBLASTOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
St. Jude Children's Research Hospital
Memphis, Tennessee, 38105, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Immunotherapy boosts chemo against tough childhood cancer
- New antibody combo shows promise in tough childhood cancer
- Experimental cancer therapy targets tough tumors with radioactive precision
- New vaccine aims to train immune system to attack childhood cancer
- New drug combo shows promise against childhood cancer
- New hope for kids with tough cancer: drug combo trial launches